$BWXT earnings report

BWX Technologies Reports Third Quarter 2026 Results. AlphAI read BWX Technologies's Third quarter 2026 filing as strong. 2 quarters are on record below.

Third quarter 2026

AlphAI · Earnings readBWXT · Third quarter 2026 · ended September 30, 2026

BWX Technologies Reports Third Quarter 2026 Results

✓Strong quarter

Third-quarter revenue, GAAP and non-GAAP earnings, adjusted EBITDA and free cash flow increased year over year, led by Commercial Operations growth and improved Government Operations earnings. BWXT reaffirmed revenue guidance and tightened its adjusted EBITDA, non-GAAP EPS and free cash flow ranges.

Revenue
$953M
10% y/y
Government Operations, three months ended September 30, 2026
$639M
4% y/y
EPS · non-GAAP
$1.26
26% y/y
Year ending December 31, 2026 outlook
~$3,800

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Revenue, three months ended September 30, 2026GAAP$953M–10%
Operating income, three months ended September 30, 2026GAAP$132.1M–17%
Operating income, three months ended September 30, 2026non-GAAP$149.7M–19%
Net income, three months ended September 30, 2026GAAP$102M–24%
Net income, three months ended September 30, 2026non-GAAP$116.3M–27%
Diluted EPS, three months ended September 30, 2026GAAP$1.11–25%
Diluted EPS, three months ended September 30, 2026non-GAAP$1.26–26%
Adjusted EBITDA, three months ended September 30, 2026non-GAAP$179.7M–19%
Operating cash flow, three months ended September 30, 2026GAAP$202.7M–42%
Capital expenditures, three months ended September 30, 2026other$52.3M–8%
Free cash flow, three months ended September 30, 2026non-GAAP$150.5M–59%
Dividends paid, three months ended September 30, 2026other$24.7M–8%
Effective tax rate, three months ended September 30, 2026GAAP22.7%––
Effective tax rate, three months ended September 30, 2026non-GAAP22.2%––
Revenue, nine months ended September 30, 2026GAAP$ 2,714,814––
Operating income, nine months ended September 30, 2026GAAP352,907––
Net income, nine months ended September 30, 2026GAAP$282.3M––
Diluted EPS, nine months ended September 30, 2026GAAP$ 3.06––
Net cash provided by operating activities, nine months ended September 30, 2026GAAP451,718––
Purchases of property, plant and equipment, nine months ended September 30, 2026other(136,200)––
Total backlog, September 30, 2026other$ 8,556,190––
Total bookings, three months ended September 30, 2026other$ 538,222––
Total bookings, nine months ended September 30, 2026other$ 3,437,452––

Segments

SegmentRevenueq/qy/y
Government Operations, three months ended September 30, 2026Growth in special materials and advanced nuclear, partially offset by lower volume in naval propulsion.$639.1M–4%
Commercial Operations, three months ended September 30, 2026Growth in commercial nuclear components, services and medical, partially offset by slightly lower fuel handling revenue.$314.2M–25%
Government Operations, nine months ended September 30, 2026Segment operating income was $ 327,416, adjusted EBITDA was not reported for the nine-month period, backlog was $ 6,481,803, and bookings were $ 2,758,269.$ 1,818,266––
Commercial Operations, nine months ended September 30, 2026Segment operating income was 74,651, adjusted EBITDA was not reported for the nine-month period, backlog was 2,074,387, and bookings were 679,183.900,360––

Year ending December 31, 2026 outlook

  • Revenue~$3,800
  • NoteAdjusted EBITDA (non-GAAP): ~$667
  • NoteNon-GAAP earnings per share: $4.72 - $4.77
  • NoteFree cash flow (non-GAAP): $350 - $360 million
  • NotePreliminary 2027 outlook: high-single-digit revenue growth.
  • NotePreliminary 2027 outlook: high-single-digit to low-double-digit adjusted EBITDA and non-GAAP EPS growth.

Capital returns

  • BWXT paid $24.7 million, or $0.27 per common share, to shareholders in the third quarter of 2026.
  • On October 28, 2026, the Board declared a quarterly cash dividend of $0.27 per common share payable on December 10, 2026, to shareholders of record on November 19, 2026.
  • Dividends paid to common shareholders for the nine months ended September 30, 2026 were (75,183).
  • Repurchases of common stock for the nine months ended September 30, 2026 were —.

What drove it

  • Government Operations revenue growth was driven by special materials and advanced nuclear, partly offset by lower naval propulsion volume.
  • Commercial Operations revenue growth was driven by commercial nuclear components, services and medical, partly offset by slightly lower fuel handling revenue.
  • Government Operations adjusted EBITDA was $144.2 million, up 22%, reflecting higher revenue and strong operating performance across business lines.
  • Commercial Operations adjusted EBITDA was $41.4 million, up 17%; higher revenue was partly offset by product and service line mix and SG&A investment to support growth.
  • Operating cash flow increased with higher net income, increased advanced billings and working-capital management, partly offset by timing of income tax payments.
  • GAAP EPS benefited from higher operating income, lower interest expense and a lower effective tax rate, partly offset by lower other income and higher restructuring and transformation and acquisition-related costs.

Concerns

  • Unallocated Corporate operating expense was $(16.8) million, compared with $(8.0) million, a 111% change.
  • Commercial Operations higher revenue was partially offset by product and service line mix and SG&A investment to support growth.
  • Government Operations growth was partially offset by lower volume in naval propulsion.
  • Total bookings were $ 538,222 for the third quarter of 2026, compared with $ 2,245,434 in the prior-year quarter.
  • The company cited federal budget uncertainty, potential government shutdowns, changing funding and acquisition priorities, supply-chain and labor-market challenges, and contract delays, changes or termination as risks.

What to watch

  • Conversion of the robust bid pipeline into firm awards, as described by management.
  • Government Operations demand in special materials, advanced nuclear and naval propulsion.
  • Commercial Operations growth in commercial nuclear components, services and medical, and the effect of product and service line mix and SG&A investment.
  • Free cash flow delivery against the tightened $350 - $360 million 2026 guidance range.
  • Progress toward the preliminary 2027 outlook for high-single-digit revenue growth and high-single-digit to low-double-digit adjusted EBITDA and non-GAAP EPS growth.

Balance sheet and cash flow

  • Cash and cash equivalents were $ 568,526 at September 30, 2026, compared with $ 499,779 at December 31, 2025.
  • Restricted cash and cash equivalents were 3,140 at September 30, 2026, compared with 3,085 at December 31, 2025.
  • Long-term debt was 2,021,883 at September 30, 2026, compared with 2,015,983 at December 31, 2025.
  • Cash and cash equivalents and restricted cash and cash equivalents at the end of the nine-month period were $ 576,803, compared with $ 86,953.
  • Net cash used in investing activities for the nine months ended September 30, 2026 was (304,892), including acquisition of businesses, net of cash acquired, of (186,967).
  • Net cash used in financing activities for the nine months ended September 30, 2026 was (81,019).

Analysis

BWXT reported broad year-over-year third-quarter growth. Revenue was $953.0 million, up 10%, while GAAP operating income increased 17% to $132.1 million and GAAP net income increased 24% to $102.0 million. Diluted GAAP EPS was $1.11, up 25%. On a non-GAAP basis, operating income was $149.7 million, net income was $116.3 million and diluted EPS was $1.26, each above the prior-year period.

Both operating segments expanded revenue. Government Operations revenue was $639.1 million, up 4%, driven by special materials and advanced nuclear, although naval propulsion volume was lower. Commercial Operations revenue rose 25% to $314.2 million on commercial nuclear components, services and medical growth. Government Operations adjusted EBITDA increased 22% to $144.2 million and Commercial Operations adjusted EBITDA increased 17% to $41.4 million. Commercial profitability faced product and service line mix and SG&A investment pressure, while consolidated unallocated corporate expense increased to $(16.8) million.

Cash generation strengthened materially in the quarter. Operating cash flow rose 42% to $202.7 million and free cash flow rose 59% to $150.5 million. Management attributed the operating-cash-flow increase to higher net income, increased advanced billings and working-capital management, partly offset by the timing of income tax payments. Third-quarter capital expenditures were $52.3 million, up 8%, primarily reflecting the timing of Commercial Operations growth projects. The company paid $24.7 million of dividends, or $0.27 per common share, during the quarter.

At September 30, 2026, BWXT reported $ 568,526 of cash and cash equivalents and 2,021,883 of long-term debt. Total backlog was $ 8,556,190, including $ 6,481,803 in Government Operations and 2,074,387 in Commercial Operations. Third-quarter total bookings were $ 538,222, compared with $ 2,245,434 in the prior-year quarter. The filing does not provide an explanation for the year-over-year booking change.

For 2026, BWXT reaffirmed revenue guidance of ~$3,800 and tightened adjusted EBITDA guidance to ~$667, non-GAAP EPS guidance to $4.72 - $4.77 and free-cash-flow guidance to $350 - $360 million. The company also introduced preliminary 2027 expectations for high-single-digit revenue growth and high-single-digit to low-double-digit adjusted EBITDA and non-GAAP EPS growth. Management stated that the 2027 adjusted EBITDA growth outlook is ahead of the framework provided at its 2026 Investor Day.

Management, verbatim

We had strong third quarter 2026 earnings performance, highlighting our intense focus on operational excellence and cash generation.

Rex. D. Geveden, president and chief executive officer

We are in the early-stages of a multi-decadal investment cycle as our customers seek to address economic security, national security, and energy security challenges with nuclear solutions.

Rex. D. Geveden, president and chief executive officer

As we look to the remainder of 2026 and into 2027, we expect continued demand momentum for nuclear solutions and increased conversion of our robust bid pipeline into firm awards.

Rex. D. Geveden, president and chief executive officer

Not in the filing

stated, not guessed
  • Gross profit and gross margin were not reported.
  • Quarterly balance-sheet cash and debt comparisons were not reported; balance-sheet amounts are reported at September 30, 2026 and December 31, 2025.
  • Free cash flow for the nine months ended September 30, 2026 was not reported.
  • GAAP guidance was not provided because the company stated it is unable to reliably forecast most items excluded from GAAP results.
  • Specific quantitative preliminary 2027 revenue, adjusted EBITDA, non-GAAP EPS and free-cash-flow guidance figures were not reported.
  • The filing did not provide a stated reason for the year-over-year decline in total third-quarter bookings.
  • The previous outlook covers the full year 2026, and this quarterly release reports only the third quarter, so there is nothing to compare.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

second quarter 2026

AlphAI · Earnings readBWXT · second quarter 2026 · ended June 30, 2026

BWX Technologies Reports Second Quarter 2026 Results

✓Strong quarter

Revenue, GAAP EPS, net income and adjusted EBITDA increased year over year, led by 72% Commercial Operations revenue growth, while the company raised 2026 revenue, adjusted EBITDA, non-GAAP EPS and free cash flow guidance.

Revenue
$902M
18% y/y
Government Operations
$601M
2% y/y
EPS · non-GAAP
$1.07
5% y/y
Year Ending December 31, 2026 outlook
~$3,800 million

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Consolidated revenuesGAAP$901.6M–18%
Consolidated operating incomeGAAP$114.1M–11%
Consolidated operating incomenon-GAAP$126.6M–5%
Government Operations operating incomeGAAP$105.7M–(3)%
Commercial Operations operating incomeGAAP$24.3M–254%
Unallocated Corporate expenseGAAP−$15.9M–14%
Diluted EPSGAAP$0.97–14%
Diluted EPSnon-GAAP$1.07–5%
Net incomeGAAP$89.1M–14%
Net incomenon-GAAP$98.6M–6%
Government Operations adjusted EBITDAnon-GAAP$126.5M–(5)%
Commercial Operations adjusted EBITDAnon-GAAP$36.1M–123%
Unallocated Corporate adjusted EBITDAnon-GAAP−$7.1M–116%
Consolidated adjusted EBITDAnon-GAAP$155.5M–7%
Operating cash flowGAAP$156.4M–(2)%
Capital expendituresother$41.4M–27%
Free cash flownon-GAAP$115M–(9)%
Dividends paidother$24.7M–6%

Segments

SegmentRevenueq/qy/y
Government OperationsGrowth in naval propulsion and special materials, partially offset by lower advanced nuclear volumes.$601.3M–2%
Commercial OperationsGrowth in commercial nuclear components, field services, fuel handling, medical, and contribution from Kinectrics, partially offset by slightly lower fuel revenue.$302.5M–72%

Year Ending December 31, 2026 outlook

  • Revenue~$3,800 million
  • NoteAdjusted EBITDA (non-GAAP): $662 million - $672 million
  • NoteNon-GAAP Earnings Per Share: $4.70 - $4.80
  • NoteFree Cash Flow (non-GAAP): $345 million - $360 million

Capital returns

  • BWXT paid $24.7 million, or $0.27 per common share, to shareholders in the second quarter of 2026.
  • On July 31, 2026, the Board of Directors declared a quarterly cash dividend of $0.27 per common share payable on September 4, 2026, to shareholders of record on August 18, 2026.

What drove it

  • Government Operations revenue growth was driven by naval propulsion and special materials.
  • Commercial Operations revenue growth included commercial nuclear components, field services, fuel handling, medical and Kinectrics.
  • Commercial Operations operating-income growth reflected higher revenue and solid operational performance, partly offset by SG&A investment to support growth.
  • The company closed the acquisition of Precision Components Group, LLC on July 1, 2026, and 2026 guidance includes its contribution.
  • The announced sale of the medical business is intended to increase focus and resources on nuclear national security and commercial nuclear power markets.

Concerns

  • Government Operations operating income declined due to higher positive contract adjustments in the same quarter last year and less favorable mix, partly offset by higher technical services equity income.
  • Government Operations adjusted EBITDA declined 5%.
  • Unallocated Corporate expense increased 14%, and Unallocated Corporate adjusted EBITDA was $(7.1) million compared with $(3.3) million.
  • Free cash flow declined 9% and capital expenditures increased 27%, primarily due to timing of growth projects in Commercial Operations.
  • Lower advanced nuclear volumes and slightly lower fuel revenue partially offset segment revenue growth.

What to watch

  • Execution against 2026 revenue guidance of ~$3,800 million.
  • Contribution from Precision Components Group, LLC following its July 1, 2026 acquisition.
  • Commercial Operations growth and the level of SG&A investment required to support it.
  • Government Operations mix, advanced nuclear volumes and contract adjustments.
  • Free cash flow delivery against $345 million - $360 million of 2026 guidance.
  • Progress on the announced sale of the medical business and the company's increased focus on its core nuclear markets.

Balance sheet and cash flow

  • Operating cash flow was $156.4 million, compared with $159.0 million.
  • Capital expenditures were $41.4 million, compared with $32.7 million.
  • Free cash flow was $115.0 million, compared with $126.3 million.
  • Operating cash flow was modestly lower as higher net income, an increase in advanced billings, and good working capital management were offset by timing of income tax payments.

Analysis

BWXT reported a strong second quarter, with consolidated revenue of $901.6 million, up 18%, and GAAP operating income of $114.1 million, up 11%. GAAP net income rose 14% to $89.1 million and diluted GAAP EPS rose 14% to $0.97. Non-GAAP operating income increased 5% to $126.6 million, non-GAAP net income increased 6% to $98.6 million, and non-GAAP EPS increased 5% to $1.07.

Commercial Operations was the primary growth contributor. Segment revenue increased 72% to $302.5 million, driven by commercial nuclear components, field services, fuel handling, medical, Kinectrics and other activity. Commercial operating income increased 254% to $24.3 million and adjusted EBITDA increased 123% to $36.1 million. Management cited higher revenue and solid operational performance, offset in part by SG&A investment to support growth.

Government Operations revenue increased 2% to $601.3 million, supported by naval propulsion and special materials, while lower advanced nuclear volumes were a partial offset. Government operating income declined 3% to $105.7 million and adjusted EBITDA declined 5% to $126.5 million. The company attributed the profit decline to higher positive contract adjustments in the prior-year quarter and less favorable mix, partly offset by higher technical services equity income. Higher corporate expense was also a partial offset to consolidated earnings growth.

Cash conversion was lower in the quarter. Operating cash flow was $156.4 million, down 2%, and free cash flow was $115.0 million, down 9%, while capital expenditures increased 27% to $41.4 million. Management cited income-tax-payment timing as the offset to higher net income, increased advanced billings and working capital management. BWXT paid $24.7 million of dividends and declared a $0.27 per common share quarterly cash dividend.

The company raised its 2026 guidance, including revenue of ~$3,800 million, adjusted EBITDA of $662 million - $672 million, non-GAAP EPS of $4.70 - $4.80 and free cash flow of $345 million - $360 million. Guidance includes the contribution from PCG, acquired on July 1, 2026. The announced sale of the medical business accompanies a strategy to focus resources on nuclear national security and commercial nuclear power markets.

Management, verbatim

We had strong second quarter 2026 results that were ahead of our expectations.

Rex. D. Geveden, president and chief executive officer

Demand for new nuclear solutions is remarkably deep and broad, complementing our strong and growing base of highly predictable revenue streams in our Government and Commercial segments.

Rex. D. Geveden, president and chief executive officer

We now anticipate adjusted EBITDA of $662 million-$672 million, non-GAAP EPS of $4.70-$4.80, and $345 million-$360 million of free cash flow.

Rex. D. Geveden, president and chief executive officer

Not in the filing

stated, not guessed
  • Gross profit and gross margin
  • Operating expenses guidance
  • Tax rate and tax-rate guidance
  • Cash balance
  • Debt balance
  • Share repurchases
  • Prior-quarter comparisons for reported metrics
  • GAAP full-year 2026 guidance
  • Previous-release outlook section for formal actual-versus-prior-guidance comparisons

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about BWXT earnings dates

When is BWX Technologies's next earnings date?
AlphAI has no date for BWXT yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.